MedTrace Logo

HPI Index With GDHT in Predicting Hypotension In General Anesthesia Patients

NCT04803903 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2021-07-30

No results posted yet for this study

Summary

The study will investigate whether the use of Goal Directed Hemodynamic Therapy implemented with the HPI algorithm using a treatment algorithm will reduce the incidence of hypotension and improve treatment of hypotension.

Conditions

  • Hypotension During Surgery

Interventions

DEVICE

Flotraq Sensor with EV1000 incorporating the HPI algorithm

The HPI algorithm is only available on the EV1000, Hemosphere and Flotrac monitoring systems and requires the use of a Flotrac sensor connected to an arterial line (Edwards Lifesciences Corp., Irvine, CA, USA). The Flotrac sensor has a splitter which enables the splitting of the arterial blood pressure signal to facilitate a blood pressure signal on both the anesthesia machine monitor (standard care) and the HemoSphere monitor (study). In the intervention arm we asked the anesthesiologist and anesthesia nurse to use the study treatment flowchart . If the HPI alarm goes off, which entails both a sound and a flickering light, we ask the anesthesiologist to act upon this alarm immedietaly. Use of the study treatment flowchart ensures that the anesthesiologist has to think about the underlying cause. The HemoSphere/EV1000 with HPI software has a second screen with variables that provide information about the underlying cause of the predicted hypotension.

Sponsors & Collaborators

  • Attikon Hospital

    lead OTHER

Principal Investigators

  • Tatiana Sidiropoulou · Attikon Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-05
Primary Completion
2021-03-30
Completion
2021-05-20

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04803903 on ClinicalTrials.gov